0 Évaluations
ID

24749

Description

Allogenic Stem Cell Transplantation (SCT) With Non-Myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL); ODM derived from: https://clinicaltrials.gov/show/NCT00644371

Lien

https://clinicaltrials.gov/show/NCT00644371

Mots-clés

Versions (1)
  1. 16/08/2017 16/08/2017 -
Téléchargé le

16 août 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Non-Hodgkin Lymphoma NCT00644371

    Anglais

    Eligibility Non-Hodgkin Lymphoma NCT00644371

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    1. written informed consent
    Description

    Informed Consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    2. histologically confirmed b-cell lymphoma of the following subtypes:
    Description

    B-Cell Lymphoma Subtype

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0079731
    UMLS CUI [1,2]
    C0449560
    lbcdl
    Description

    Diffuse Large B-Cell Lymphoma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0079744
    grade 3b follicular lymphoma
    Description

    Follicular Lymphoma Ann Arbor lymphoma staging system

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0024301
    UMLS CUI [1,2]
    C0432516
    mantle-cell lymphoma
    Description

    Mantle-cell lymphoma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0334634
    transformed b-cell lymphoma
    Description

    B-Cell Lymphoma Transformation

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0079731
    UMLS CUI [1,2]
    C1536010
    burkitt lymphoma in patients not eligible for a conventional allogeneic transplant
    Description

    Burkitt Lymphoma | Patient Inappropriate Allogeneic Transplantation

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0006413
    UMLS CUI [2,1]
    C0030705
    UMLS CUI [2,2]
    C1548788
    UMLS CUI [2,3]
    C0040739
    3. high-risk b-cell cd20+ lymphoma defined by
    Description

    B-Cell Lymphoma CD20 positive High risk of

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0079731
    UMLS CUI [1,2]
    C0882818
    UMLS CUI [1,3]
    C0332167
    having attained less than pr after two chemotherapy lines
    Description

    Chemotherapy cycle Quantity | Partial response Less Than

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1302181
    UMLS CUI [1,2]
    C1265611
    UMLS CUI [2,1]
    C1521726
    UMLS CUI [2,2]
    C0439092
    post-transplantation relapse
    Description

    Recurrent disease Post Transplantation

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0277556
    UMLS CUI [1,2]
    C0687676
    UMLS CUI [1,3]
    C0040732
    presence of disease detected through a metabolic approach (pet/ct or else ct+pet) either before or after autologous transplantation
    Description

    Disease detection PET/CT Before Autologous Transplantation | Disease detection CT Before Autologous Transplantation | Disease detection PET Before Autologous Transplantation | Disease detection PET/CT Post Autologous Transplantation | Disease detection CT Post Autologous Transplantation | Disease detection PET Post Autologous Transplantation

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0683509
    UMLS CUI [1,2]
    C1699633
    UMLS CUI [1,3]
    C0332152
    UMLS CUI [1,4]
    C0040736
    UMLS CUI [2,1]
    C0683509
    UMLS CUI [2,2]
    C0040405
    UMLS CUI [2,3]
    C0332152
    UMLS CUI [2,4]
    C0040736
    UMLS CUI [3,1]
    C0683509
    UMLS CUI [3,2]
    C0032743
    UMLS CUI [3,3]
    C0332152
    UMLS CUI [3,4]
    C0040736
    UMLS CUI [4,1]
    C0683509
    UMLS CUI [4,2]
    C1699633
    UMLS CUI [4,3]
    C0687676
    UMLS CUI [4,4]
    C0040736
    UMLS CUI [5,1]
    C0683509
    UMLS CUI [5,2]
    C0040405
    UMLS CUI [5,3]
    C0687676
    UMLS CUI [5,4]
    C0040736
    UMLS CUI [6,1]
    C0683509
    UMLS CUI [6,2]
    C0032743
    UMLS CUI [6,3]
    C0687676
    UMLS CUI [6,4]
    C0040736
    inability to collect enough stem cells for autologous transplantation
    Description

    Transplantation, Autologous | Stem cell Collection Unable

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0040736
    UMLS CUI [2,1]
    C0038250
    UMLS CUI [2,2]
    C1516698
    UMLS CUI [2,3]
    C1299582
    4. stable disease at the time of transplantation
    Description

    Stable Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0677946
    5. age between 18 and 65
    Description

    Age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    6. performance status (ecog) ≤ 2
    Description

    ECOG performance status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    7. normal and suitable pulmonary function (dlco ≥ 30%)
    Description

    Pulmonary function | Carbon Monoxide Diffusing Capability Test

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0231921
    UMLS CUI [2]
    C1516251
    8. left ventricular ejection fraction (lvef) determined by ventriculography or echocardiogram ≥ 40%
    Description

    Left ventricular ejection fraction Ventriculography | Left ventricular ejection fraction Echocardiography

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0428772
    UMLS CUI [1,2]
    C0596683
    UMLS CUI [2,1]
    C0428772
    UMLS CUI [2,2]
    C0013516
    9. normal hepatic and renal function, with creatinine ≤ 2 mg/dl and bi ≤ 1.5 mg/dl, and alkaline phosphatase ≤ 2.5 x unl ; ast, alt ≤ 2.5 x unl (≤ 5 x unl if hepatic infiltration)
    Description

    Liver function | Renal function | Creatinine measurement, serum | Serum total bilirubin measurement | Alkaline phosphatase measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Infiltration Hepatic

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0232741
    UMLS CUI [2]
    C0232804
    UMLS CUI [3]
    C0201976
    UMLS CUI [4]
    C1278039
    UMLS CUI [5]
    C0201850
    UMLS CUI [6]
    C0201899
    UMLS CUI [7]
    C0201836
    UMLS CUI [8,1]
    C0332448
    UMLS CUI [8,2]
    C0205054
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    1. prior treatment with radiopharmaceutical agents
    Description

    Radiopharmaceuticals

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0182638
    2. hiv-associated lymphoma
    Description

    Lymphoma, HIV-Related

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0085090
    3. presence of human anti-mouse antibodies (hama) or anti-chimeric antibodies (haca)
    Description

    Human anti-mouse antibody | Human antichimeric Ab

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1291910
    UMLS CUI [2]
    C1317433
    4. patient's inability to follow the protocol
    Description

    Protocol Compliance Unable

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0525058
    UMLS CUI [1,2]
    C1299582
    5. hypersensitivity to 90y-itritumomab tiuxetan
    Description

    Hypersensitivity yttrium-90-ibritumomab tiuxetan

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C1134535
    6. presence of severe pathologies that preclude chemotherapeutic treatment
    Description

    Pathology Severe Excludes Chemotherapy

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0677042
    UMLS CUI [1,2]
    C0205082
    UMLS CUI [1,3]
    C0332196
    UMLS CUI [1,4]
    C0392920
    7. pregnant women or pregnancy risk due to inappropriate contraceptive measures
    Description

    Pregnancy | Contraceptive methods Inappropriate | Pregnancy Risk

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2,1]
    C0700589
    UMLS CUI [2,2]
    C1548788
    UMLS CUI [3,1]
    C0032961
    UMLS CUI [3,2]
    C0035647
    8. breastfeeding women
    Description

    Breast Feeding

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0006147
    Retour au début de la page

    Similar models

    Eligibility Non-Hodgkin Lymphoma NCT00644371

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Informed Consent
    Item
    1. written informed consent
    boolean
    C0021430 (UMLS CUI [1])
    B-Cell Lymphoma Subtype
    Item
    2. histologically confirmed b-cell lymphoma of the following subtypes:
    boolean
    C0079731 (UMLS CUI [1,1])
    C0449560 (UMLS CUI [1,2])
    Diffuse Large B-Cell Lymphoma
    Item
    lbcdl
    boolean
    C0079744 (UMLS CUI [1])
    Follicular Lymphoma Ann Arbor lymphoma staging system
    Item
    grade 3b follicular lymphoma
    boolean
    C0024301 (UMLS CUI [1,1])
    C0432516 (UMLS CUI [1,2])
    Mantle-cell lymphoma
    Item
    mantle-cell lymphoma
    boolean
    C0334634 (UMLS CUI [1])
    B-Cell Lymphoma Transformation
    Item
    transformed b-cell lymphoma
    boolean
    C0079731 (UMLS CUI [1,1])
    C1536010 (UMLS CUI [1,2])
    Burkitt Lymphoma | Patient Inappropriate Allogeneic Transplantation
    Item
    burkitt lymphoma in patients not eligible for a conventional allogeneic transplant
    boolean
    C0006413 (UMLS CUI [1])
    C0030705 (UMLS CUI [2,1])
    C1548788 (UMLS CUI [2,2])
    C0040739 (UMLS CUI [2,3])
    B-Cell Lymphoma CD20 positive High risk of
    Item
    3. high-risk b-cell cd20+ lymphoma defined by
    boolean
    C0079731 (UMLS CUI [1,1])
    C0882818 (UMLS CUI [1,2])
    C0332167 (UMLS CUI [1,3])
    Chemotherapy cycle Quantity | Partial response Less Than
    Item
    having attained less than pr after two chemotherapy lines
    boolean
    C1302181 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    C1521726 (UMLS CUI [2,1])
    C0439092 (UMLS CUI [2,2])
    Recurrent disease Post Transplantation
    Item
    post-transplantation relapse
    boolean
    C0277556 (UMLS CUI [1,1])
    C0687676 (UMLS CUI [1,2])
    C0040732 (UMLS CUI [1,3])
    Disease detection PET/CT Before Autologous Transplantation | Disease detection CT Before Autologous Transplantation | Disease detection PET Before Autologous Transplantation | Disease detection PET/CT Post Autologous Transplantation | Disease detection CT Post Autologous Transplantation | Disease detection PET Post Autologous Transplantation
    Item
    presence of disease detected through a metabolic approach (pet/ct or else ct+pet) either before or after autologous transplantation
    boolean
    C0683509 (UMLS CUI [1,1])
    C1699633 (UMLS CUI [1,2])
    C0332152 (UMLS CUI [1,3])
    C0040736 (UMLS CUI [1,4])
    C0683509 (UMLS CUI [2,1])
    C0040405 (UMLS CUI [2,2])
    C0332152 (UMLS CUI [2,3])
    C0040736 (UMLS CUI [2,4])
    C0683509 (UMLS CUI [3,1])
    C0032743 (UMLS CUI [3,2])
    C0332152 (UMLS CUI [3,3])
    C0040736 (UMLS CUI [3,4])
    C0683509 (UMLS CUI [4,1])
    C1699633 (UMLS CUI [4,2])
    C0687676 (UMLS CUI [4,3])
    C0040736 (UMLS CUI [4,4])
    C0683509 (UMLS CUI [5,1])
    C0040405 (UMLS CUI [5,2])
    C0687676 (UMLS CUI [5,3])
    C0040736 (UMLS CUI [5,4])
    C0683509 (UMLS CUI [6,1])
    C0032743 (UMLS CUI [6,2])
    C0687676 (UMLS CUI [6,3])
    C0040736 (UMLS CUI [6,4])
    Transplantation, Autologous | Stem cell Collection Unable
    Item
    inability to collect enough stem cells for autologous transplantation
    boolean
    C0040736 (UMLS CUI [1])
    C0038250 (UMLS CUI [2,1])
    C1516698 (UMLS CUI [2,2])
    C1299582 (UMLS CUI [2,3])
    Stable Disease
    Item
    4. stable disease at the time of transplantation
    boolean
    C0677946 (UMLS CUI [1])
    Age
    Item
    5. age between 18 and 65
    boolean
    C0001779 (UMLS CUI [1])
    ECOG performance status
    Item
    6. performance status (ecog) ≤ 2
    boolean
    C1520224 (UMLS CUI [1])
    Pulmonary function | Carbon Monoxide Diffusing Capability Test
    Item
    7. normal and suitable pulmonary function (dlco ≥ 30%)
    boolean
    C0231921 (UMLS CUI [1])
    C1516251 (UMLS CUI [2])
    Left ventricular ejection fraction Ventriculography | Left ventricular ejection fraction Echocardiography
    Item
    8. left ventricular ejection fraction (lvef) determined by ventriculography or echocardiogram ≥ 40%
    boolean
    C0428772 (UMLS CUI [1,1])
    C0596683 (UMLS CUI [1,2])
    C0428772 (UMLS CUI [2,1])
    C0013516 (UMLS CUI [2,2])
    Liver function | Renal function | Creatinine measurement, serum | Serum total bilirubin measurement | Alkaline phosphatase measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Infiltration Hepatic
    Item
    9. normal hepatic and renal function, with creatinine ≤ 2 mg/dl and bi ≤ 1.5 mg/dl, and alkaline phosphatase ≤ 2.5 x unl ; ast, alt ≤ 2.5 x unl (≤ 5 x unl if hepatic infiltration)
    boolean
    C0232741 (UMLS CUI [1])
    C0232804 (UMLS CUI [2])
    C0201976 (UMLS CUI [3])
    C1278039 (UMLS CUI [4])
    C0201850 (UMLS CUI [5])
    C0201899 (UMLS CUI [6])
    C0201836 (UMLS CUI [7])
    C0332448 (UMLS CUI [8,1])
    C0205054 (UMLS CUI [8,2])
    Item Group
    C0680251 (UMLS CUI)
    Radiopharmaceuticals
    Item
    1. prior treatment with radiopharmaceutical agents
    boolean
    C0182638 (UMLS CUI [1])
    Lymphoma, HIV-Related
    Item
    2. hiv-associated lymphoma
    boolean
    C0085090 (UMLS CUI [1])
    Human anti-mouse antibody | Human antichimeric Ab
    Item
    3. presence of human anti-mouse antibodies (hama) or anti-chimeric antibodies (haca)
    boolean
    C1291910 (UMLS CUI [1])
    C1317433 (UMLS CUI [2])
    Protocol Compliance Unable
    Item
    4. patient's inability to follow the protocol
    boolean
    C0525058 (UMLS CUI [1,1])
    C1299582 (UMLS CUI [1,2])
    Hypersensitivity yttrium-90-ibritumomab tiuxetan
    Item
    5. hypersensitivity to 90y-itritumomab tiuxetan
    boolean
    C0020517 (UMLS CUI [1,1])
    C1134535 (UMLS CUI [1,2])
    Pathology Severe Excludes Chemotherapy
    Item
    6. presence of severe pathologies that preclude chemotherapeutic treatment
    boolean
    C0677042 (UMLS CUI [1,1])
    C0205082 (UMLS CUI [1,2])
    C0332196 (UMLS CUI [1,3])
    C0392920 (UMLS CUI [1,4])
    Pregnancy | Contraceptive methods Inappropriate | Pregnancy Risk
    Item
    7. pregnant women or pregnancy risk due to inappropriate contraceptive measures
    boolean
    C0032961 (UMLS CUI [1])
    C0700589 (UMLS CUI [2,1])
    C1548788 (UMLS CUI [2,2])
    C0032961 (UMLS CUI [3,1])
    C0035647 (UMLS CUI [3,2])
    Breast Feeding
    Item
    8. breastfeeding women
    boolean
    C0006147 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial